Portfolio & Capacity Planning
Singleplex, multiplex, syndromic and quantitative PCR portfolios mapped to demand, batch size and localization phases.
Start a project ↗Infinity IVD develops integrated PCR and molecular-test manufacturing facilities covering reagent formulation, precision filling, kit assembly, molecular quality control, cold chain and technology transfer.

The project begins with the intended assay menu, required output, fill format and localization depth. From there, Infinity IVD coordinates clean-area zoning, process equipment, utilities, quality controls and digital traceability into a scalable manufacturing system.
Singleplex, multiplex, syndromic and quantitative PCR portfolios mapped to demand, batch size and localization phases.
Dedicated workflows for buffers, enzymes, oligonucleotides and master-mix formulation with defined hold times and traceability.
Protected preparation, dilution, aliquoting and storage strategies designed to preserve identity and reduce contamination risk.
Manual, semi-automatic or automated dispensing into tubes, strips, plates or cartridges with weight and closure controls.
Facility and equipment concepts can be configured for liquid, dried or mixed portfolios according to the transferred process.
Optional integration of extraction reagents, magnetic-bead workflows and compatible sample-preparation consumables.
Controlled labeling, component counting, secondary packaging, monitored storage and shipment preparation.
Extraction, real-time PCR, contamination monitoring, functional release and stability infrastructure planned as one system.
URS, qualification protocols, SOPs, batch records, deviation controls, calibration and maintenance framework.
Assay transfer, engineering batches, process verification, operator training and controlled production ramp-up.

Infinity IVD combines process engineering, clean-area planning, equipment selection, assay transfer and operator training in one project. Process design protects sensitive reagents, separates higher-risk molecular activities and builds traceability into every stage. Automation is selected where it improves dispensing accuracy, consistency and throughput.
Personnel, raw materials, oligonucleotides, formulated reagents, amplified material, waste and finished kits follow defined routes. Exact classification and pressure strategy are finalized for the transferred process and national requirements.
Infinity IVD plans the QC laboratory around the intended assays, extraction methods, instruments and acceptance criteria. The framework can support development transfer, in-process checks, release testing and lifecycle monitoring.

The final package is configured for the investor, selected assays and destination market without making unsupported product or regulatory claims.